Cargando…

Toward a Risk-Utility Data Governance Framework for Research Using Genomic and Phenotypic Data in Safe Havens: Multifaceted Review

BACKGROUND: Research using genomic data opens up new insights into health and disease. Being able to use the data in association with health and administrative record data held in safe havens can multiply the benefits. However, there is much discussion about the use of genomic data with perceptions...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Kerina, Daniels, Helen, Heys, Sharon, Lacey, Arron, Ford, David V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260661/
https://www.ncbi.nlm.nih.gov/pubmed/32412420
http://dx.doi.org/10.2196/16346
_version_ 1783540365975879680
author Jones, Kerina
Daniels, Helen
Heys, Sharon
Lacey, Arron
Ford, David V
author_facet Jones, Kerina
Daniels, Helen
Heys, Sharon
Lacey, Arron
Ford, David V
author_sort Jones, Kerina
collection PubMed
description BACKGROUND: Research using genomic data opens up new insights into health and disease. Being able to use the data in association with health and administrative record data held in safe havens can multiply the benefits. However, there is much discussion about the use of genomic data with perceptions of particular challenges in doing so safely and effectively. OBJECTIVE: This study aimed to work toward a risk-utility data governance framework for research using genomic and phenotypic data in an anonymized form for research in safe havens. METHODS: We carried out a multifaceted review drawing upon data governance arrangements in published research, case studies of organizations working with genomic and phenotypic data, public views and expectations, and example studies using genomic and phenotypic data in combination. The findings were contextualized against a backdrop of legislative and regulatory requirements and used to create recommendations. RESULTS: We proposed recommendations toward a risk-utility model with a flexible suite of controls to safeguard privacy and retain data utility for research. These were presented as overarching principles aligned to the core elements in the data sharing framework produced by the Global Alliance for Genomics and Health and as practical control measures distilled from published literature and case studies of operational safe havens to be applied as required at a project-specific level. CONCLUSIONS: The recommendations presented can be used to contribute toward a proportionate data governance framework to promote the safe, socially acceptable use of genomic and phenotypic data in safe havens. They do not purport to eradicate risk but propose case-by-case assessment with transparency and accountability. If the risks are adequately understood and mitigated, there should be no reason that linked genomic and phenotypic data should not be used in an anonymized form for research in safe havens.
format Online
Article
Text
id pubmed-7260661
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-72606612020-08-06 Toward a Risk-Utility Data Governance Framework for Research Using Genomic and Phenotypic Data in Safe Havens: Multifaceted Review Jones, Kerina Daniels, Helen Heys, Sharon Lacey, Arron Ford, David V J Med Internet Res Original Paper BACKGROUND: Research using genomic data opens up new insights into health and disease. Being able to use the data in association with health and administrative record data held in safe havens can multiply the benefits. However, there is much discussion about the use of genomic data with perceptions of particular challenges in doing so safely and effectively. OBJECTIVE: This study aimed to work toward a risk-utility data governance framework for research using genomic and phenotypic data in an anonymized form for research in safe havens. METHODS: We carried out a multifaceted review drawing upon data governance arrangements in published research, case studies of organizations working with genomic and phenotypic data, public views and expectations, and example studies using genomic and phenotypic data in combination. The findings were contextualized against a backdrop of legislative and regulatory requirements and used to create recommendations. RESULTS: We proposed recommendations toward a risk-utility model with a flexible suite of controls to safeguard privacy and retain data utility for research. These were presented as overarching principles aligned to the core elements in the data sharing framework produced by the Global Alliance for Genomics and Health and as practical control measures distilled from published literature and case studies of operational safe havens to be applied as required at a project-specific level. CONCLUSIONS: The recommendations presented can be used to contribute toward a proportionate data governance framework to promote the safe, socially acceptable use of genomic and phenotypic data in safe havens. They do not purport to eradicate risk but propose case-by-case assessment with transparency and accountability. If the risks are adequately understood and mitigated, there should be no reason that linked genomic and phenotypic data should not be used in an anonymized form for research in safe havens. JMIR Publications 2020-05-15 /pmc/articles/PMC7260661/ /pubmed/32412420 http://dx.doi.org/10.2196/16346 Text en ©Kerina Jones, Helen Daniels, Sharon Heys, Arron Lacey, David V Ford. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 15.05.2020. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on http://www.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
Jones, Kerina
Daniels, Helen
Heys, Sharon
Lacey, Arron
Ford, David V
Toward a Risk-Utility Data Governance Framework for Research Using Genomic and Phenotypic Data in Safe Havens: Multifaceted Review
title Toward a Risk-Utility Data Governance Framework for Research Using Genomic and Phenotypic Data in Safe Havens: Multifaceted Review
title_full Toward a Risk-Utility Data Governance Framework for Research Using Genomic and Phenotypic Data in Safe Havens: Multifaceted Review
title_fullStr Toward a Risk-Utility Data Governance Framework for Research Using Genomic and Phenotypic Data in Safe Havens: Multifaceted Review
title_full_unstemmed Toward a Risk-Utility Data Governance Framework for Research Using Genomic and Phenotypic Data in Safe Havens: Multifaceted Review
title_short Toward a Risk-Utility Data Governance Framework for Research Using Genomic and Phenotypic Data in Safe Havens: Multifaceted Review
title_sort toward a risk-utility data governance framework for research using genomic and phenotypic data in safe havens: multifaceted review
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260661/
https://www.ncbi.nlm.nih.gov/pubmed/32412420
http://dx.doi.org/10.2196/16346
work_keys_str_mv AT joneskerina towardariskutilitydatagovernanceframeworkforresearchusinggenomicandphenotypicdatainsafehavensmultifacetedreview
AT danielshelen towardariskutilitydatagovernanceframeworkforresearchusinggenomicandphenotypicdatainsafehavensmultifacetedreview
AT heyssharon towardariskutilitydatagovernanceframeworkforresearchusinggenomicandphenotypicdatainsafehavensmultifacetedreview
AT laceyarron towardariskutilitydatagovernanceframeworkforresearchusinggenomicandphenotypicdatainsafehavensmultifacetedreview
AT forddavidv towardariskutilitydatagovernanceframeworkforresearchusinggenomicandphenotypicdatainsafehavensmultifacetedreview